Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 605, pseudogene (RN7SL605P)** is a human pseudogene derived from the 7SL RNA, which is the non-coding RNA component of the signal recognition particle (SRP). The SRP is essential for targeting newly synthesized proteins to the endoplasmic reticulum, but the pseudogenes (including RN7SL605P) are non-functional copies within the genome that do not produce an active RNA product necessary for SRP activity[1][5]. Instead, 7SL pseudogenes like RN7SL605P are thought to arise via reverse transcription from mature RNAs and are present in many truncated forms[5]. While pseudogenes can sometimes have regulatory roles at the RNA level (e.g., by acting as competitive endogenous RNAs, producing siRNAs, or interacting with RNA-binding proteins), there is no evidence that RN7SL605P is a therapeutic target, encodes a protein, or plays a direct functional role in disease[4][5][6]. Its primary relevance is as a genomic remnant related to the functional 7SL RNA gene. **Key points:** - This entity is a **pseudogene** and not a therapeutic target, enzyme, receptor, transporter, or functional protein. - No drugs, mechanisms of action, or direct biomarker or safety implications are associated with RN7SL605P. - It has sequence similarity to functional 7SL RNA, but its primary utility is genomic annotation and evolutionary study[5]. If more information about the functional 7SL RNA or the broader SRP complex is needed, this can be provided separately.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 605, pseudogene (RN7SL605P).